Rapamycin Shows Promise for Cardiac Health in Elderly Adults
Small trial tests whether rapamycin, an FDA-approved drug, can improve heart function and immune response in people aged 70-95.
2017 articles in this topic
Small trial tests whether rapamycin, an FDA-approved drug, can improve heart function and immune response in people aged 70-95.
Small study tests whether protein blends can help older adults maintain muscle mass and strength through improved protein synthesis.
Six-month trial examines whether metformin treatment can improve telomere length and longevity gene expression in prediabetic individuals.
144-person study explores how rapamycin, amino acids, and resistance exercise combat sarcopenia and muscle wasting in aging adults.
Small trial tests whether leucine supplementation enhances muscle-building effects of resistance exercise in frail elderly women.
FDA-approved transplant drug tested in 70-95 year olds to combat age-related immune decline and improve longevity markers.
Greek researchers investigated whether whey protein can counter inflammation-driven muscle loss in older adults with chronic inflammation.
McMaster study compares whole milk, skim milk, and almond beverage effects on muscle protein synthesis in aging women.
58-person trial compared resveratrol's effects to calorie restriction on insulin sensitivity, gene expression, and cardiovascular markers.
Intensive vipassana meditation retreat showed measurable improvements in biological markers linked to aging and inflammation.
Researchers analyzed epigenetic changes in 124 Israeli centenarians to understand the molecular basis of exceptional longevity.
Nine-year study compared kidney adaptation between young and older donors, revealing insights for safe organ donation.